IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 388 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $214,000 | 0.0% | 3,536 | -1.1% | 0.01% | -16.7% |
| Q3 2019 | $214,000 | -6.1% | 3,576 | +1.0% | 0.01% | +9.1% |
| Q2 2019 | $228,000 | -2.1% | 3,541 | -18.0% | 0.01% | -35.3% |
| Q4 2018 | $233,000 | +4.5% | 4,316 | 0.0% | 0.02% | +41.7% |
| Q3 2018 | $223,000 | -98.3% | 4,316 | -98.4% | 0.01% | -97.3% |
| Q4 2016 | $13,101,000 | +30.5% | 273,900 | 0.0% | 0.45% | +36.8% |
| Q3 2016 | $10,036,000 | +57.3% | 273,900 | 0.0% | 0.33% | +41.2% |
| Q2 2016 | $6,379,000 | -33.3% | 273,900 | +16.1% | 0.23% | -33.0% |
| Q1 2016 | $9,558,000 | -27.2% | 236,000 | +11.3% | 0.35% | -23.0% |
| Q4 2015 | $13,129,000 | – | 212,000 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |